维普中文期刊产品整合服务
29篇 您的检索式:作者名="Lim TO"
    题名 作者 年代 出处 被引量
1Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology(Carlton)2005,10,5:1
2Randomized con- trolled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of prolifer- ative lupus nephritis显示文摘Ong LM Hooi LS Lim TO Nephrology (Carlton)0,10,5:1
3Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferate lupus nephritis 显示文摘Ong LM Hooi LS Lim TO 2005Nephrology2005,10,5:1
4Endoscopic treatment of dieulafoy lesions and risk factors for rebleeding显示文摘Lim W Kim TO Park SB 2009Korean J Intern Med2009,24,4:1
5Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology (Carlton)2005,10,:1
6EGFL7 Is Expressed in Bone Microenvironment and Promotes Angiogenesis via ERK, STAT3, and Integrin Signaling Cascades显示文摘Shek Man Chim Vincent Kuek Siu To Chow Bay Sie Lim Jennifer Tickner Jinmin Zhao Rosa Chung Yu‐Wen Su Ge Zhang Wendy Erber Cory J. Xian Vicki Rosen Jiake Xu 2015Physiol2015,,1:1
7Endoscopic treatment of Dieu- lafoy Lesions and risk factors for rebleeding显示文摘Lim W Kim TO Park SB 2009Korean J Intern Med2009,24,4:1
8Endcscopic Treatment ~f Dieulafoy Lesions and Risk Factors for Rebleedlng显示文摘Lim W Kim TO Park SB 2009Korean J Intern Med2009,24,4:1
91 molecule by molecular modeling显示文摘Lim JS Kim S Lee HG et aL Selection of peptides that bind to the HLA-A2 1996Mol Immunol1996,33,2:1
10Endoscopic treatment of Dieulafoy lesions and risk factors for rebleeding显示文摘Lim W Kim TO Park SB 2009Korean J lntern Med2009,24,4:1
11Endoscopic treatment of dieulafoy lesions and risk factors for rebleeding显示文摘Lim W Kim TO Park SB et aL 2009Korean J Intern Med2009,24,4:1
12Randomized controlled trial of pulseintravenous cyclophosphamide versus mycophenolate mofetil in the in-duction therapy of proliferative lupus nephritis 显示文摘OngLM Hooi LS Lim TO 2005Nephrology2005,10,:1
13Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis 显示文摘Ong LM Hooi LS Lim TO 2005Nephrology (Carlton)2005,10,5:1
14Endoscopic TreatMent of Dieulafoy Lesions and Risk Factors for Rcbleedin 显示文摘Lim W Kim TO Park SB 2009Korean J Intern Med2009,24,4:1
15Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology2005,10,:1
16Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology (Carlton)2005,10,5:1
17Endoscopic Treatment of Dieulafoy Lesions a nd Risk Factors for Rebleeding显示文摘Lim W Kim TO Park SB 2009Korean J Intern Med2009,24,4:1
18Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology (Carlton)2005,10,5:1
19Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology (Carlton)2005,10,5:1
20Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis显示文摘Ong LM Hooi LS Lim TO 2005Nephrology(Carlton)2005,10,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费